Center for Molecular Medicine Cologne

In progress - further information will follow soon.

  • Jiang Q, Stachelscheid J, Bloehdorn J, Pacholewska A, Aszyk C, Grotenhuijs F, Muller T, Onder O, Wagle P, Herling CD, Kleppe M, Wang Z, Coombes KR, Robrecht S, Dalvi PS, Plosnita B, Mayer P, Abruzzo LV, Altmuller J, Gathof B, Persigehl T, Fischer K, Jebaraj B, Rienhoff HY, Ecker R, Zhao Y, Bruns CJ, Stilgenbauer S, Elenitoba-Johnson K, Hallek M, Schweiger MR, Odenthal M, Vasyutina E, and Herling M (2023). Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia. Blood 142, 44-61. doi:10.1182/blood.2022017230.
     
  • Stachelscheid J, Jiang Q, Aszyk C, Warner K, Bley N, Muller T, Vydzhak O, Symeonidis K, Crispatzu G, Mayer P, Blakemore SJ, Goehring G, Newrzela S, Hippler S, Robrecht S, Kreuzer KA, Pallasch C, Kruger M, Lechner A, Fischer K, Stilgenbauer S, Beutner D, Hallek M, Auguin D, Huttelmaier S, Bloehdorn J, Vasyutina E, and Herling M (2023). The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL. Blood 141, 1425-1441. doi:10.1182/blood.2022015494.
PD Dr. Marco Herling CMMC Cologne
PD Dr. Marco Herling

Clinic I of Internal Medicine

CMMC assoc. RG. 25

+49 221 478 51464

+49 221 478-93883

Clinic I of Internal Medicine

Universitiy Hospital Cologne Weyertal 115c

50931 Cologne

https://herlinglab.com/

CMMC Profile Page

Curriculum Vitae (CV)

Publications on PubMed

Publications

Link to PubMed